• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYHL2500080 格隆溴铵新斯的明注射液 glycopyrronium bromide;neostigmine Injection Chemical Drugs(3) Generic Drug 2025-04-14 Chengdu Nuohe Shenghong Biopharmaceutical Co Ltd view
CXHL2200582 格隆溴铵吸入喷雾剂 glycopyrronium bromide Spray Chemical Drugs(2.2) New Drug Application 2022-08-11 Anovent Pharmaceuticals Co Ltd view
CYHB2400395 格隆溴铵新斯的明注射液 glycopyrronium bromide;neostigmine Injection Chemical Drugs(3) Supplementary Application 2024-03-19 Nantong No 3 Pharmaceutical Factory;Chengdu Hepatunn Pharmaceutical Co Ltd view
JYHZ2400336 茚达特罗格隆溴铵吸入粉雾剂 glycopyrronium bromide;indacaterol maleate Powder for inhalation Chemical Drugs License Renew 2024-11-29 Siegfried Barbera SL;Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG view
CYHL2101022 格隆溴铵新斯的明注射液 glycopyrronium bromide;neostigmine Injection Chemical Drugs(3) Generic Drug 2021-08-10 Reyoung Pharmaceutical Co Ltd view
JYHB2300164 格隆溴铵吸入粉雾剂 glycopyrronium bromide Powder for inhalation Chemical Drugs Supplementary Application 2023-03-07 Siegfried Barbera SL;Novartis Pharma Schweiz AG view
JYHB2300339 茚达特罗格隆溴铵吸入粉雾剂 glycopyrronium bromide;indacaterol maleate Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2023-06-19 Siegfried Barbera SL;Novartis Pharma Schweiz AG view
JYHZ2400247 格隆溴铵福莫特罗吸入气雾剂 formoterol fumarate;glycopyrronium bromide Aerosol Chemical Drugs(5.1) License Renew 2024-09-19 AstraZeneca AB;Astrazeneca Investment (China) Co Ltd;Bespak HC Ltd view
CXHB2101021 格隆溴铵吸入粉雾剂 glycopyrronium bromide Powder for inhalation Chemical Drugs(原3.1) Supplementary Application 2021-05-14 Sichuan Haisco Pharmaceutical Co Ltd view
CYHL2300120 格隆溴铵新斯的明注射液 glycopyrronium bromide;neostigmine Injection Chemical Drugs(3) Generic Drug 2023-09-20 Zhejiang Fenghua Pharmaceutical Technology Co Ltd view
JYHB2400605 茚达特罗格隆溴铵吸入粉雾剂 glycopyrronium bromide;indacaterol maleate Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2024-11-19 Siegfried Barbera SL;Novartis Pharma Schweiz AG view
JYHB2101218 格隆溴铵福莫特罗吸入气雾剂 formoterol fumarate;glycopyrronium bromide Aerosol Chemical Drugs(5.1) Supplementary Application 2021-06-29 AstraZeneca AB;Recipharm Hc Ltd view
JYHB2300163 格隆溴铵吸入粉雾剂 glycopyrronium bromide Powder for inhalation Chemical Drugs Supplementary Application 2023-03-07 Siegfried Barbera SL;Novartis Pharma Schweiz AG view
CYHL2400130 格隆溴铵新斯的明注射液 glycopyrronium bromide;neostigmine Injection Chemical Drugs(3) Generic Drug 2024-06-26 Chengdu Nuohe Shenghong Biopharmaceutical Co Ltd view
CYHL2200090 格隆溴铵新斯的明注射液 glycopyrronium bromide;neostigmine Injection Chemical Drugs(3) Generic Drug 2022-10-14 Jiangsu Huataichenguang Pharmaceuticals INC view
CYHL2500074 茚达特罗格隆溴铵吸入粉雾剂 glycopyrronium bromide;indacaterol maleate Powder for inhalation Chemical Drugs(4) Generic Drug 2025-04-08 CF PharmTech Inc view
CYHL2200089 格隆溴铵新斯的明注射液 glycopyrronium bromide;neostigmine Injection Chemical Drugs(3) Generic Drug 2022-10-14 Nantong No 3 Pharmaceutical Factory view
CYHL2300081 茚达特罗格隆溴铵吸入粉雾剂 glycopyrronium bromide;indacaterol maleate Powder for inhalation Chemical Drugs(4) Generic Drug 2023-06-27 Respirent Pharmaceuticals Co Ltd view
JYHB2400606 茚达特罗格隆溴铵吸入粉雾剂 glycopyrronium bromide;indacaterol maleate Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2024-11-19 Siegfried Barbera SL;Novartis Pharma Schweiz AG view
CYHL2300031 格隆溴铵吸入粉雾剂 glycopyrronium bromide Powder for inhalation Chemical Drugs(4) Generic Drug 2023-03-02 CF PharmTech Inc view